English
español
Please use this identifier to cite or link to this item:
http://hdl.handle.net/10261/97029
Share/Impact:
Statistics |
![]() ![]() ![]() |
|
|
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |||
|
Title: | In vitro bactericidal activity of the antiprotozoal drug miltefosine against Streptococcus pneumoniae and other pathogenic streptococci |
Authors: | Llull, Daniel ![]() ![]() ![]() |
Issue Date: | May-2007 |
Publisher: | American Society for Microbiology |
Citation: | Antimicrobial Agents and Chemotherapy 51(5) 1844- 1848 (2007) |
Abstract: | Miltefosine (hexadecylphosphocholine), the first oral drug against visceral leishmaniasis, triggered pneumococcal autolysis at concentrations higher than 2.5 μM. Bactericidal activity was also observed in cultures of other streptococci, although these failed to undergo lysis. The autolysis elicited by miltefosine can be attributed to triggering of the pneumococcal autolysin LytA. Copyright © 2007, American Society for Microbiology. All Rights Reserved. |
Publisher version (URL): | http://dx.doi.org/10.1128/AAC.01428-06 |
URI: | http://hdl.handle.net/10261/97029 |
DOI: | 10.1128/AAC.01428-06 |
ISSN: | 0066-4804 |
Appears in Collections: | (CIB) Artículos |
Files in This Item:
There are no files associated with this item.
Show full item record
Review this work
Review this work
Related articles:
WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.